M&A

A report said the conglomerate Abbott Laboratories is close to a deal to acquire the company.

Dycom reported fiscal third-quarter earnings per share of $3.63 from sales of $1.5 billion. Wall Street was looking for $3.20 and $1.5 billion, respectively, according to FactSet.

The victor will walk away with the rights to beloved characters including Harry Potter, Superman, and Tony Soprano.

Adobe to acquire Semrush for $12 a share.

LPL joins Private Advisor Group’s other backer, Merchant Investment Management, which bought a minority stake in the wealth management company in 2021.

GTCR is extending its reach in wealth management. It already owns AssetMark.

The purchase of Hemington Wealth Management adds a team of 16 and continues Beacon Pointe’s aggressive acquisition campaign.

Alphabet rose after Berkshire Hathaway disclosed that it bought $4.3 billion worth of shares in the third quarter.

Halda is testing a prostate cancer drug. J&J says that with the acquisition it will gain a platform for treating “diseases beyond oncology.”

Sinclair is eyeing a takeover of its local media rival, but Scripps may not be ready to sell just yet.

Cidara Therapeutics is developing a drug designed to prevent the flu.

Get ready for a bidding war, as three of the world’s biggest media companies go toe-to-toe for the rights to Harry Potter and Batman.

Wednesday, USA Rare Earth said it had received U.K. approval to buy Less Common Metals.

The AI software firm discloses a $250 million deal to acquire another defense-focused AI platform.

The increase could very well extend into the next couple of years, even though buyers have already spent heavily. This has important, and positive, implications for stock investors.

The purchase of Apexium Financial is United Capital’s second acquisition of the year, and more are in the pipeline.

It’s the second report of a takeover in a matter of weeks.

Shares of eVTOL maker Archer Aviation rose early Monday after a brutal sell off this past week.

Metsera falls sharply after Pfizer agrees to buy the weight-loss drug start-up in a deal that could be worth more than $10 billion.

Certain traits consistently stand out to buyers—strong organic growth, a solid management team, and profitability—but there are many more variables to consider.

The food processor will be acquired by Investindustrial, a European investment firm.

The deal to acquire Northern Data will allow Rumble to obtain more than 40,000 Nvidia graphics processing units.

The Danish drugmaker's shareholders appear relieved that it hasn't overpaid for largely unproven treatments.

Legacy media companies are trying to beef up their offerings, to fend off competition from streaming platforms.

Contingent value rights have become common in biotechnology deals. More than half of all transactions this year include them, according to a Jefferies report in October.